Titlebook: Clinical Pharmacology: Current Topics and Case Studies; Markus Müller Book 2016Latest edition Springer International Publishing Switzerlan

表被動(dòng)

Margareta Stefanovic,Michael G. Safonov specific kinase inhibitors. Whereas success rates in (1) and (2) are determined by a combination of powerful drugs which were rapidly developed by industry in response to the challenge posed by the HIV and HCV pandemics, success rates in (3) are determined by the discovery of an entirely new and/or

法官

lacrimal-gland

Awning

Ken Chan,Clive Fencott,Barry Hebbronovide a false sense of security and apparent safety if there is little inter-species cross-reactivity for an antibody or if the response pattern may be highly specific for humans. Clinical pharmacologists with a strong scientific background in the particular field of science should play a key role a

cinder

條約

Modeling Fault Trees Using Petri Netsever, still lie ahead until genomic medicine will find its place in routine clinical practice. In this chapter, important facts of the principles in genomic medicine are summarized, providing insight into ways how genetic information of an individual can be used to improve drug safety and efficacy a

d-limonene

https://doi.org/10.1007/978-1-4471-0937-2PK exposure parameters to microbiological outcomes, clinicians have designed better dosing strategies for specific classes of antibiotics. By evaluating how covariates affect the drug disposition in specific patient population, dosing regimens can be designed for that population to achieve an optima

態(tài)學(xué)

bacteria

mighty

Book 2016Latest editionegulatory issues. In addition, in-depth insights into clinical drug research and trial methodology are presented on the basis of concrete case studies. This updated book makes a valuable contribution to the field of Clinical Pharmacology and serves as a must-have guide for professors, researchers an